Panther Fusion® Open Access
Bring Simplicity & Performance to In-House Testing
LDTs are an essential part of diagnostics. Patients with certain medical conditions depend on these in-house developed tests when other options are not available. When laboratories process LDTs alongside In vitro Diagnostic (IVD) assays, it can help save time and expenditures, enhancing efficiency. Panther Fusion Open Access technology puts lab technicians in control of their workflow. From laborious in-house assay development to delivering up to 335 results in an 8 hour shift.1
Fully Automate & Consolidate Your Molecular Platforms
Simplify & Scale the Future of Diagnostics
Consolidation in Practice
Time to first result
Optimise Today & Prepare for Tomorrow
Evidence. Insight. Collaboration.
Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.
- AW-26055-001 Rev. 001 Panther / Panther Fusion Operators Manual San Diego, Ca; Hologic Inc. 2022
- Bluel B, Accola M, Rehrauer W. Evaluation of Open Access™ on the Hologic Panther Fusion® System, Poster presented at: European Congress of Clinical Microbiology and Infectious Disease 2018; Apr 21-24: Madrid, Spain
Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.
Notified Body number wherever applicable